Bringing the fundamentals into focus…
Back to ADC Therapeutics SA
How ADC Therapeutics SA stacks up
ADCT · against 200 other Healthcare companies of similar size
Growth
17/ 100
Near the bottom of its peers.
Ranked #150 of 201 · scores higher than 24% of peers
Bars: peers in each 10-point band of the growth score28 peers with a growth score of 10–19, including ADCT · Click a bar to see the companies
Why growth scores 17?
Weighted metrics compared with all Healthcare companies.Mainly because of its 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over three years: weaker than 95% of peers. 3-year revenue growth: -24.4% vs peer median 5.8%
- slower revenue growth over the last year: weaker than 61% of peers. Revenue growth: 3.0% vs peer median 6.1%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = ADCT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ADCT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 210 reported | 3.0% | 3.0% | 50% | 33% | |
| Earnings per share growthHigher is better · 81 reported | Not reported | 0.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 195 reported | -24.4% | 3.2% | 6% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around ADCTScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score